SAN DIEGO, Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing several candidates it has selected a Contract Research ...
SEATTLE, Aug. 20, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast ...
SYDNEY--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development ...
Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation, Therapeutic ...
According to MarketsandMarkets, the Contract Research Organization (CRO) Services Market is projected to grow from about USD 93.02 billion ...
SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma ...
WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter ...
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance ...
Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ...
During this session, the panelists discussed the current market outlook for CROs and the key differentiators making them attractive to private equity investors, such as therapeutic area (TA) ...
Polaryx Therapeutics shares were 66% higher, at $4.01, after the company said it has selected a leading contract research organization for its phase 2 trial designed to evaluate the safety, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果